BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35092577)

  • 21. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.
    Troyanov Y; Targoff IN; Payette MP; Raynauld JP; Chartier S; Goulet JR; Bourré-Tessier J; Rich E; Grodzicky T; Fritzler MJ; Joyal F; Koenig M; Senécal JL
    Medicine (Baltimore); 2014 Nov; 93(24):318-332. PubMed ID: 25500701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myositis-specific and myositis-associated autoantibodies in a large Indian cohort of inflammatory myositis.
    Gupta L; Naveen R; Gaur P; Agarwal V; Aggarwal R
    Semin Arthritis Rheum; 2021 Feb; 51(1):113-120. PubMed ID: 33360322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies.
    Hengstman GJ; Brouwer R; Egberts WT; Seelig HP; Jongen PJ; van Venrooij WJ; van Engelen BG
    J Neurol; 2002 Jan; 249(1):69-75. PubMed ID: 11954871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of clinical characteristics and laboratory parameters of patients with dermatomyositis-specific autoantibodies and autoantibody-negative patients].
    Bodoki L; Budai D; Nagy-Vincze M; Griger Z; Betteridge Z; Dankó K
    Orv Hetil; 2015 Sep; 156(36):1451-9. PubMed ID: 26320599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of Myositis Autoantibodies by Multi-Analytic Immunoassays in a Large Multicenter Cohort of Patients with Definite Idiopathic Inflammatory Myopathies.
    Ghirardello A; Gatto M; Franco C; Zanatta E; Padoan R; Ienna L; Gallo N; Zen M; Lundberg IE; Mahler M; Doria A; Iaccarino L
    Diagnostics (Basel); 2023 Sep; 13(19):. PubMed ID: 37835823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myositis-associated antibodies predict the severity of lung involvement in adult patients with inflammatory myositis - a cohort study of 70 adult patients with myositis in a single center.
    Marklund J; Hanna B; Jin T; Pullerits R
    Front Med (Lausanne); 2024; 11():1340310. PubMed ID: 38606156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcinosis and malignancy are rare in Chinese adult patients with myositis and nuclear matrix protein 2 antibodies identified by an unlabeled immunoprecipitation assay.
    Wang L; Huang L; Yang Y; Chen H; Liu Y; Liu K; Liu M; Xiao Y; Luo H; Zuo X; Li Y; Xiao X; Zhang H
    Clin Rheumatol; 2018 Oct; 37(10):2731-2739. PubMed ID: 30039266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dermatomyositis: Clinical features and pathogenesis.
    DeWane ME; Waldman R; Lu J
    J Am Acad Dermatol; 2020 Feb; 82(2):267-281. PubMed ID: 31279808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets.
    Merlo G; Clapasson A; Cozzani E; Sanna L; Pesce G; Bagnasco M; Burlando M; Parodi A
    Arch Dermatol Res; 2017 Mar; 309(2):87-95. PubMed ID: 27928683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical subsets of juvenile dermatomyositis classified by myositis-specific autoantibodies: Experience at a single center in Japan.
    Iwata N; Nakaseko H; Kohagura T; Yasuoka R; Abe N; Kawabe S; Sugiura S; Muro Y
    Mod Rheumatol; 2019 Sep; 29(5):802-807. PubMed ID: 30092736
    [No Abstract]   [Full Text] [Related]  

  • 31. Myositis autoantibody profiles and their clinical associations in Greek patients with inflammatory myopathies.
    Zampeli E; Venetsanopoulou A; Argyropoulou OD; Mavragani CP; Tektonidou MG; Vlachoyiannopoulos PG; Tzioufas AG; Skopouli FN; Moutsopoulos HM
    Clin Rheumatol; 2019 Jan; 38(1):125-132. PubMed ID: 30145635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The analysis of clinical phenotypes and autoantibodies in juvenile dermatomyositis].
    Li DM; Wang L; Liu MY; Xu L; Tang XM
    Zhonghua Er Ke Za Zhi; 2020 Dec; 58(12):966-972. PubMed ID: 33256317
    [No Abstract]   [Full Text] [Related]  

  • 33. Myositis-specific autoantibodies and their clinical associations in idiopathic inflammatory myopathies: results from a cohort from China.
    Wen L; Chen X; Cheng Q; Nie L; Xu J; Yan T; Zhang X; Yang H; Sun W; Liu L; Xue J; Du Y
    Clin Rheumatol; 2022 Nov; 41(11):3419-3427. PubMed ID: 35859245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Heterogeneity of Patients With Antinuclear Matrix Protein 2 Antibody-Positive Myositis: A Retrospective Cohort Study in China.
    Li S; Sun C; Zhang L; Han J; Yang H; Gao S; He L; Zhang P; Lu X; Shu X; Wang G
    J Rheumatol; 2022 Aug; 49(8):922-928. PubMed ID: 35705242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subsets of Idiopathic Inflammatory Myositis Enriched for Contemporaneous Cancer Relative to the General Population.
    Mecoli CA; Igusa T; Chen M; Wang X; Albayda J; Paik JJ; Tiniakou E; Adler B; Richardson C; Kelly W; Danoff S; Mammen AL; Platz EA; Rosen A; Christopher-Stine L; Casciola-Rosen L; Shah AA
    Arthritis Rheumatol; 2023 Apr; 75(4):620-629. PubMed ID: 35878018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical value of cancer-associated myositis-specific antibodies, anti-transcriptional intermediary factor 1-γ, and anti-nuclear matrix protein 2 antibodies in a retrospective cohort of dermatomyositis/polymyositis in a Japanese community hospital.
    Suga T; Oiwa H; Ishida M; Iwamoto Y
    Clin Rheumatol; 2022 Sep; 41(9):2803-2808. PubMed ID: 35399148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Muscle Biopsy Features with Myositis Autoantibodies in Inflammatory Myopathies: A Pilot Experience.
    Gudipati A; Rifat S; Uppin M; Jabeen A; Mathukumalli NL; Yareeda S; Kayidhi S; Pyal A; Dhamne M; Reddy YM
    Ann Indian Acad Neurol; 2023; 26(4):408-418. PubMed ID: 37970294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoantibodies Recognizing Specificity Protein 4 Co-occur With Anti-Transcription Intermediary Factor 1 and Are Associated With Distinct Clinical Features and Immunogenetic Risk Factors in Juvenile Myositis.
    Sherman MA; Pak K; Pinal-Fernandez I; Flegel WA; Targoff IN; Miller FW; Rider LG; Mammen AL;
    Arthritis Rheumatol; 2023 Sep; 75(9):1668-1677. PubMed ID: 36996276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis.
    Gunawardena H; Wedderburn LR; Chinoy H; Betteridge ZE; North J; Ollier WE; Cooper RG; Oddis CV; Ramanan AV; Davidson JE; McHugh NJ;
    Arthritis Rheum; 2009 Jun; 60(6):1807-14. PubMed ID: 19479859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Myositis specific and myositis associated autoantibodies in idiopathic inflammatory myopathies: a serologic study of 46 patients].
    Ghirardello A; Zampieri S; Iaccarino L; Tarricone E; Tonello M; Bendo R; Rondinone R; Cozzi F; Doria A
    Reumatismo; 2005; 57(1):22-8. PubMed ID: 15776143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.